20 October, 2020

European Attack

The very core of India's subsidy policy is under threat

European Attack

INDIAN antibiotic exports are a threat to the European pharmaceutical industry! It may sound like a compliment first, but in fact it's the first step to another non-tariff barrier against Indian exports. The allegation—from the European pharma industry—has resulted in the first anti-subsidy investigation against Indian exports.

An anti-subsidy investigation is different, and in some ways more serious than, an anti-dumping one, insofar as it takes an intrusive swipe at policy and involves the government of a country directly. It's the Indian government's subsidy schemes and the advantages that accrue to Indian exporters under them that are now being assailed. And all this is happening legitimately under the WTO agreement to which India is a signatory. In the new world economic order, India is on the defensive once again.

In July, the European Community pharmaceutical industry submitted a formal request for anti-subsidy investigations against Indian antibiotic exports. "The commission decided there was sufficient...



To read this piece, and more such stories in India's most exciting and exacting magazine, plus get access to our 25-year archives goldmine, please subscribe.

In this article:

More from Payal Kohli

Latest Magazine

October 26, 2020

other articles from the issue

articles from the previous issue

Other magazine section